کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5899245 | 1155591 | 2015 | 7 صفحه PDF | دانلود رایگان |
- Our results showed impaired performance in MMSE, Trails B, digit span and block design.
- T2DM should be considered to be a risk factor for cognitive impairment in elderly.
- Diabetic-related factors may associate with the risk of cognitive impairment in T2DM.
AimTo identify characteristics of neuropsychological function among elderly individuals with Type 2 diabetes mellitus with mild cognitive impairment (T2DM-MCI) and evaluate domain-specific effects of T2DM on cognition.MethodsThis was a cross-sectional study conducted in Tianjin, China. MCI subjects (n = 246) and controls were identified in elderly individuals with diabetes, and groups were matched in a 1:1 ratio for sex, age and educational level. Cognitive function was assessed using WAIS-III (block design, digit span), Trail Making Test A, Trail Making Test B, WMS-III (word list learning, logical memory), verbal fluency and MMSE. We used multivariable logistic regression to find diabetic factors associated with MCI.ResultsThe mean MMSE score was 22.73 ± 2.32 in subjects with T2DM-MCI, versus 26.71 ± 2.43 in subjects cognitive normal (P < 0.001). Executive and visuospatial functions were more impaired in individuals with T2DM-MCI than in those without, as assessed using block design (P < 0.001), digit span test (P < 0.001), and Trails B (P < 0.001). For memory, subjects with T2DM-MCI did worse than those cognitive normal on the word learning list delayed recall (P = 0.015). Diabetic-related factors such as longer duration of T2DM, higher HbA1c, insulin treatment was associated with a lower level of cognitive functioning using MMSE, block design, delayed recall and Trails B test.ConclusionsT2DM should be considered a risk factor for MCI. This risk may be associated with duration of diabetes, use of glucose-lowering medications, degree of glucose control. To decrease risk of MCI, it is important to monitor glucose control and adjust medications appropriately in elderly patients.
Journal: Diabetes Research and Clinical Practice - Volume 109, Issue 2, August 2015, Pages 299-305